Oral chemotherapy in colorectal cancer treatment: review of the literature
Authors:
- Emmanuel AndrèsEmmanuel Andrès
- Shanti Natarajan-AméSNShanti Natarajan-Amé
- Esther NoelENEsther Noel
- Patrick DufourPDPatrick Dufour
- 1 February 2003
- journal article
- review article
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 14 (1) , 18-25
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Oral Versus Intravenous Fluoropyrimidines for Advanced Colorectal Cancer: By Either Route, It’s All the SameJournal of Clinical Oncology, 2001
- Answering Patients' Needs: Oral Alternatives to Intravenous TherapyThe Oncologist, 2001
- Preoperative chemoradiotherapy with oral doxifluridine plus low-dose oral leucovorin in unresectable primary rectal cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2001
- Conventional cytotoxic and novel therapeutic concepts in colorectal cancerExpert Opinion on Investigational Drugs, 2001
- Capecitabine, an Oral Fluoropyrimidine Carbamate With Substantial Activity in Advanced Colorectal Cancer: Results of a Randomized Phase II StudyJournal of Clinical Oncology, 2000
- New insights into the pyrimidine salvage pathway of Saccharomyces cerevisiae: requirement of six genes for cytidine metabolismCurrent Genetics, 1999
- Colorectal cancerThe Lancet, 1999
- Results of leucovorin and doxifluridine oral regimen in the treatment of metastatic colorectal cancerAnti-Cancer Drugs, 1998
- Preliminary studies of a novel oral fluoropyrimidine carbamate: capecitabine.Journal of Clinical Oncology, 1998
- Patient preferences for oral versus intravenous palliative chemotherapy.Journal of Clinical Oncology, 1997